In addition, patients with high PRMT7 expression showed suggestively significantly worse overall survival (P = 0.1) and significantly worse relapse-free survival than those with low PRMT7 expression in HCC patients of TCGA LIHC (P = 0.002, Supplementary Fig. 20). The gene discussed is PRMT7; the disease is hepatocellular carcinoma.